Novo Holdings was already one of the world’s biggest investors in new biopharma companies, but its reach and influence has grown over the last 12 months or so thanks to windfalls not just from the success of Novo Nordisk, but also its own run of hit investments and sales of biotech start-ups.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?